108 related articles for article (PubMed ID: 27600091)
1. Clinical features and genetic diagnosis of hereditary spinocerebellar ataxia 3.
Wang Y; Yang X; Ma W; Li J; Zhang Q; Xia S; Wang H; Zhang C; Xu X; Zheng J
Mol Med Rep; 2016 Oct; 14(4):3731-4. PubMed ID: 27600091
[TBL] [Abstract][Full Text] [Related]
2. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
3. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3.
Li QF; Cheng HL; Yang L; Ma Y; Zhao JJ; Dong Y; Wu ZY
Mol Genet Genomic Med; 2020 Sep; 8(9):e1314. PubMed ID: 32643267
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features and gene mutation analysis in Machado-Joseph disease of spinocerebellar ataxia type 3 in littoral of Zhejiang].
Jin YY; Zeng AP; Cai HB; Wu F; Feng Z; Hong Q; Zhang L; Jiang ZK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):132-4. PubMed ID: 20104758
[TBL] [Abstract][Full Text] [Related]
7. Triplet Repeat Primed PCR (TP-PCR) in Molecular Diagnostic Testing for Spinocerebellar Ataxia Type 3 (SCA3).
Melo AR; Ramos A; Kazachkova N; Raposo M; Bettencourt BF; Rendeiro AR; Kay T; Vasconcelos J; Bruges-Armas J; Lima M
Mol Diagn Ther; 2016 Dec; 20(6):617-622. PubMed ID: 27647319
[TBL] [Abstract][Full Text] [Related]
8. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
[TBL] [Abstract][Full Text] [Related]
9. [Detection and analysis of dynamic variant in a pedigree affected with spinocerebellar ataxia type 3].
Chen C; Zhao X; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1364-1367. PubMed ID: 33306823
[TBL] [Abstract][Full Text] [Related]
10. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China].
Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919
[TBL] [Abstract][Full Text] [Related]
11. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of MJD1 alleles and molecular analysis of SCA3 patients from Rio de Janeiro, Brazil.
Gestinari RS; Duarte SF; Pimentel MM; Lima MA
Genet Test; 2004; 8(3):281-5. PubMed ID: 15727252
[TBL] [Abstract][Full Text] [Related]
13. Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients.
Raposo M; Bettencourt C; Ramos A; Kazachkova N; Vasconcelos J; Kay T; Bruges-Armas J; Lima M
Neuromolecular Med; 2017 Mar; 19(1):41-45. PubMed ID: 27246313
[TBL] [Abstract][Full Text] [Related]
14. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
15. Homozygosity enhances severity in spinocerebellar ataxia type 3.
Carvalho DR; La Rocque-Ferreira A; Rizzo IM; Imamura EU; Speck-Martins CE
Pediatr Neurol; 2008 Apr; 38(4):296-9. PubMed ID: 18358414
[TBL] [Abstract][Full Text] [Related]
16. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
17. Chinese homozygous Machado-Joseph disease (MJD)/SCA3: a case report.
Zeng S; Zeng J; He M; Zeng X; Zhou Y; Liu Z; Jiang H; Tang B; Wang J
J Hum Genet; 2015 Mar; 60(3):157-60. PubMed ID: 25566755
[TBL] [Abstract][Full Text] [Related]
18. Variation of CAG repeats and two intragenic polymorphisms at SCA3 locus among Machado-Joseph disease/SCA3 patients and diverse normal populations from eastern India.
Chattopadhyay B; Basu P; Gangopadhyay PK; Mukherjee SC; Sinha KK; Chakraborty A; Roy T; Roychoudhury S; Majumder PP; Bhattacharyya NP
Acta Neurol Scand; 2003 Dec; 108(6):407-14. PubMed ID: 14616293
[TBL] [Abstract][Full Text] [Related]
19. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
[TBL] [Abstract][Full Text] [Related]
20. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
